Ascella Biosystems


Developer of a handheld, point-of-care molecular diagnostic platform for rapid detection of viral RNA. The platform is described as providing multiplex detection from a single sample with results reported via a mobile application. The team reports expertise in molecular biology, biochemistry, and medical device hardware engineering and notes support from government research funding and private investors.

Industries

biotechnology

Nr. of Employees

small (1-50)

Ascella Biosystems

San Francisco, California, United States, North America


Products

Handheld rapid multiplex molecular diagnostic device

A compact, handheld point-of-care device that performs rapid molecular detection of viral RNA and multiplex testing from a single sample, with results displayed via a companion mobile application.


Services

Mobile test management and result submission service

Mobile application service that guides users through sample collection, displays test results, stores test records, and enables sharing or submission of results to external parties.

Expertise Areas

  • Molecular diagnostics
  • Point-of-care testing
  • Multiplex viral detection
  • Portable medical device engineering
  • Show More (4)

Key Technologies

  • Multiplex nucleic acid detection
  • Rapid molecular assay platform (sub-6-minute turnaround)
  • Handheld diagnostic hardware
  • Mobile application for test guidance and result management
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.